Molecular Cancer Therapeutics,
Journal Year:
2024,
Volume and Issue:
23(5), P. 638 - 647
Published: Feb. 5, 2024
Abstract
Drug
resistance
is
the
major
determinant
for
metastatic
disease
and
fatalities,
across
all
cancers.
Depending
on
tissue
of
origin
therapeutic
course,
a
variety
biological
mechanisms
can
support
sustain
drug
resistance.
Although
genetic
mutations
gene
silencing
through
epigenetic
are
culprits
in
targeted
therapy,
efflux
polyploidization
more
global
that
prevail
broad
range
pathologies,
response
to
treatments.
There
an
unmet
need
identify
patients
at
risk
polyploidy,
understand
underlying
polyploidization,
develop
strategies
predict,
limit,
reverse
polyploidy
thus
enhancing
efficacy
standard-of-care
therapy
improve
better
outcomes.
This
literature
review
provides
overview
cancer
offers
perspective
patient
monitoring
actionable
therapy.
npj Precision Oncology,
Journal Year:
2022,
Volume and Issue:
6(1)
Published: May 4, 2022
Prostate
cancer
is
characterized
by
a
high
degree
of
heterogeneity,
which
poses
major
challenge
to
precision
therapy
and
drug
development.
In
this
review,
we
discuss
how
nongenetic
factors
contribute
heterogeneity
prostate
cancer.
We
also
tumor
phenotypic
switching
related
anticancer
therapies.
Lastly,
summarize
the
challenges
targeting
environments,
emphasize
that
continued
exploration
needed
in
order
offer
personalized
for
advanced
patients.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(9), P. 4723 - 4723
Published: April 25, 2022
Cell
division
and
cell
death
are
fundamental
processes
governing
growth
development
across
the
tree
of
life.
This
relationship
represents
an
evolutionary
link
between
cycle
programs
that
is
present
in
all
cells.
Cancer
characterized
by
aberrant
regulation
both,
leading
to
unchecked
proliferation
replicative
immortality.
Conventional
anti-cancer
therapeutic
strategies
take
advantage
proliferative
dependency
cancer
yet,
doing
so,
triggering
apoptosis,
a
pathway
which
inherently
resistant.
A
thorough
understanding
how
therapeutics
kill
cells
needed
develop
novel,
more
durable
treatment
strategies.
While
evolves
cell-intrinsic
resistance
physiological
pathways,
there
opportunities
for
agnostic
forms
death,
example,
necroptosis
or
ferroptosis.
Furthermore,
independent
immunogenic,
potentially
licensing
host
immunity
additional
antitumor
activity.
Identifying
vulnerabilities
critical
developing
alternative
can
overcome
resistance.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(7), P. 3542 - 3542
Published: March 24, 2022
DNA
replication
during
cell
proliferation
is
‘vertical’
copying,
which
reproduces
an
initial
amount
of
genetic
information.
Polyploidy,
results
from
whole-genome
duplication,
a
fundamental
complement
to
vertical
copying.
Both
organismal
and
polyploidy
can
emerge
via
premature
cycle
exit
or
cell-cell
fusion,
the
latter
giving
rise
polyploid
hybrid
organisms
epigenetic
hybrids
somatic
cells.
Polyploidy-related
increase
in
biological
plasticity,
adaptation,
stress
resistance
manifests
evolution,
development,
regeneration,
aging,
oncogenesis,
cardiovascular
diseases.
Despite
prevalence
nature
importance
for
medicine,
agri-
aquaculture,
processes
mechanisms
underlying
these
features
largely
remain
unknown.
The
evolutionarily
conserved
include
activation
transcription,
response
stress,
damage
hypoxia,
induction
programs
morphogenesis,
unicellularity,
longevity,
suggesting
that
common
confer
adaptive
viability,
cells
organisms.
By
increasing
polyploidization
provide
survival
under
stressful
conditions
where
diploid
cannot
survive.
However,
it
occurs
at
expense
specific
function,
thus
promoting
developmental
programming
adult
diseases
risk
cancer.
Notably,
genes
arising
evolutionary
are
heavily
involved
cancer
other
Ploidy-related
changes
gene
expression
presumably
originate
chromatin
modifications
derepression
bivalent
genes.
provided
evidence
elucidates
role
carcinogenesis,
may
contribute
development
new
strategies
regeneration
preventing
Neoplasia,
Journal Year:
2023,
Volume and Issue:
42, P. 100906 - 100906
Published: May 10, 2023
The
emergence
of
chemotherapy
resistance
drives
cancer
lethality
in
patients,
with
treatment
initially
reducing
overall
tumor
burden
followed
by
resistant
recurrent
disease.
While
molecular
mechanisms
underlying
phenotypes
have
been
explored,
less
is
known
about
the
cell
biological
characteristics
cells
that
survive
to
eventually
seed
recurrence.
To
identify
unique
phenotypic
associated
survival
upon
exposure,
we
characterized
nuclear
morphology
and
function
as
prostate
recovered
following
cisplatin
treatment.
Cells
survived
days
weeks
after
resisted
therapy-induced
death
showed
increasing
size
size,
enabled
continuous
endocycling
resulting
repeated
whole
genome
doubling.
We
further
found
therapy
release
were
predominantly
mononucleated
likely
employ
more
efficient
DNA
damage
repair.
Finally,
show
surviving
exhibit
a
distinct
nucleolar
phenotype
increased
rRNA
levels.
These
data
support
paradigm
where
soon
release,
treated
population
mostly
contains
high
level
widespread
catastrophic
leads
apoptosis,
while
minority
successful
DDR
are
access
pro-survival
state.
findings
consistent
accession
polyaneuploid
(PACC)
state,
recently
described
mechanism
Our
demonstrate
fate
define
key
PACC
This
work
essential
for
understanding
and,
ultimately,
targeting
Clinical and Translational Medicine,
Journal Year:
2024,
Volume and Issue:
14(2)
Published: Feb. 1, 2024
Abstract
Tumour
cell
dormancy
is
critical
for
metastasis
and
resistance
to
chemoradiotherapy.
Polyploid
giant
cancer
cells
(PGCCs)
with
or
multiple
nuclei
high
DNA
content
have
the
properties
of
stem
single
PGCCs
can
individually
generate
tumours
in
immunodeficient
mice.
represent
a
dormant
form
that
survive
harsh
tumour
conditions
contribute
recurrence.
Hypoxic
mimics,
chemotherapeutics,
radiation
cytotoxic
traditional
Chinese
medicines
induce
formation
through
endoreduplication
and/or
fusion.
After
incubation,
recover
from
treatment
produce
daughter
strong
proliferative,
migratory
invasive
abilities
via
asymmetric
division.
Additionally,
resist
hypoxia
chemical
stress
distinct
protein
signature
involves
chromatin
remodelling
cycle
regulation.
Dormant
cellular
basis
therapeutic
resistance,
metastatic
cascade
disease
This
review
summarises
regulatory
mechanisms
governing
entry
exit
dormancy,
which
may
be
used
by
PGCCs,
potential
strategies
targeting
PGCCs.
Molecular & Cellular Proteomics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100949 - 100949
Published: March 1, 2025
This
study
delves
into
the
proteomic
intricacies
of
drug-resistant
cells
(DRCs)
within
prostate
cancer,
which
are
known
for
their
pivotal
roles
in
therapeutic
resistance,
relapse,
and
metastasis.
Utilizing
single-cell
proteomics
(SCP)
with
an
optimized
high-throughput
Data
Independent
Acquisition
(DIA)
approach
throughput
60
sample
per
day,
we
characterized
landscape
DRCs
comparison
to
parental
PC3
cells.
DIA
method
allowed
robust
reproducible
protein
quantification
at
level,
enabling
identification
over
1,300
proteins
cell
on
average.
Distinct
sub-clusters
DRC
population
were
identified,
closely
linked
variations
size.
The
uncovered
novel
signatures,
including
regulation
critical
adhesion
metabolic
processes,
as
well
upregulation
surface
transcription
factors
cancer
progression.
Furthermore,
by
conducting
RNA-seq
(scRNA-seq)
analysis,
identified
six
upregulated
ten
downregulated
genes
consistently
altered
drug-treated
across
both
SCP
scRNA-seq
platforms.
These
findings
underscore
heterogeneity
unique
molecular
providing
valuable
insights
biological
behavior
potential
targets.
Frontiers in Oncology,
Journal Year:
2021,
Volume and Issue:
11
Published: Aug. 30, 2021
Polyploidy
is
a
conserved
mechanism
in
cell
development
and
stress
responses.
Multiple
stresses
of
treatment,
including
radiation
chemotherapy
drugs,
can
induce
the
polyploidization
tumor
cells.
Through
endoreplication
or
fusion,
diploid
cells
convert
into
giant
with
single
large
nuclei
multiple
small
nucleuses.
Some
stress-induced
colossal
cells,
which
were
previously
thought
to
be
senescent
have
no
ability
proliferate,
escape
fate
death
by
special
way.
They
remain
alive
at
least
before
producing
progeny
through
asymmetric
division,
depolyploidization
way
named
neosis.
Those
danger
are
recognized
as
polyploid
cancer
(PGCCs).
Such
under
suspicion
being
highly
related
recurrence
metastasis
after
treatment
bring
new
targets
for
therapy.
However,
differences
formation
mechanisms
between
PGCCs
well-accepted
largely
unknown.
In
this
review,
methods
used
different
studies
summarized,
several
demonstrated.
Besides,
we
discuss
some
characteristics
poor
prognosis
caused
order
provide
readers
more
comprehensive
understanding
these
huge
Annual Review of Genetics,
Journal Year:
2022,
Volume and Issue:
56(1), P. 165 - 185
Published: Aug. 17, 2022
Though
cell
size
varies
between
different
cells
and
across
species,
the
nuclear-to-cytoplasmic
(N/C)
ratio
is
largely
maintained
species
within
types.
A
maintains
a
relatively
constant
N/C
by
coupling
DNA
content,
nuclear
size,
size.
We
explore
how
couple
division
growth
to
content.
In
some
cases,
use
as
molecular
yardstick
control
availability
of
cycle
regulators.
other
sets
limit
for
biosynthetic
capacity.
Developmentally
programmed
variations
in
given
type
suggest
that
specific
required
respond
physiological
demands.
Recent
observations
connecting
decreased
ratios
with
cellular
senescence
indicate
maintaining
proper
essential
functioning.
Together,
these
findings
causative,
not
simply
correlative,
role
regulating
progression.
Viruses,
Journal Year:
2022,
Volume and Issue:
14(11), P. 2462 - 2462
Published: Nov. 7, 2022
Human
cytomegalovirus
(HCMV)
is
a
herpesvirus
that
infects
between
40%
and
95%
of
the
population
worldwide,
usually
without
symptoms.
The
host
immune
response
keeps
virus
in
latent
stage,
although
HCMV
can
reactivate
an
inflammatory
context,
which
could
result
sequential
lytic/latent
viral
cycles
during
lifetime
thereby
participate
genomic
diversity
humans.
high
level
intra-host
variability
oncomodulatory
role
where
will
favor
development
spread
cancerous
cells.
Recently,
oncogenic
has
been
highlighted
directly
transform
primary
cells;
such
strains
are
named
high-risk
(HR)
strains.
In
light
these
new
findings,
this
review
defines
criteria
characterize
HR-HCMV
their
molecular
as
well
phenotypic
impact
on
infected
cell
its
tumor
microenvironment.